f-IPV

BIOLOGICAL2 trials

Sponsors

Fidec Corporation

Conditions

Poliomyelitis

Phase 3

A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine

WithdrawnNCT03016949

Fidec CorporationPoliomyelitis

Start: 2017-07-31End: 2018-11-30Updated: 2017-06-27

A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

CompletedNCT03239496

Fidec CorporationPoliomyelitis

Start: 2017-10-23End: 2018-11-13Updated: 2023-07-21

Related Papers

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial.

2020-10-2322 citations